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The thalamic reticular nucleus – A communication hub   
 Abstract 
The thalamus (comprising many distinct nuclei) plays a key role in facilitating sensory 
discrimination and cognitive processes through connections with the cortex . Impaired 
thalamocortical processing has long been considered to be involved in schizophrenia. In this 
review we focus on the thalamic reticular nucleus (TRN) providing evidence for it being an 
important communication hub between the thalamus and cortex and how it may play a key 
role in the pathophysiology of schizophrenia. We first highlight the functional neuroanatomy, 
neurotransmitter localisation and physiology of the TRN.  We then present evidence of the 
physiological roles of the TRN in relation to oscillatory activity, cognition and behaviour. Next 
we discuss the role of the TRN in rodent models of risk factors for schizophrenia (genetic 
and pharmacological) and provide evidence for TRN deficits in schizophrenia.  Finally we 
discuss new drug targets for schizophrenia in relation to restoring TRN circuitry dysfunction. 
     
  
 The thalamus is composed of many distinct nuclei that have reciprocal topographically 
organised connections with sensory, motor, limbic and cognitive regions of the cortex.  
Although it was traditionally considered to be a simple relay station, it is now clear that the 
thalamus plays a key role in the processing and integration of information (Jones, 2007).A 
thalamic nucleus of particular importance in regulating thalamocortical function is the TRN.   
 
The TRN  is a thin sheet of GABAergic neurones that surrounds other thalamic nuclei 
(Houser et al., 1980; Mitrofanis and Guillery, 1993; Steriade et al., 1997). Glutamatergic 
projections from the cortex pass through the TRN en route to the thalamus, innervating TRN 
cells via collateral fibres. Thalamocortical glutamatergic projections also provide a collateral 
innervation of TRN neurones. Unlike other thalamic nuclei, the TRN does not send direct 
projections to the cerebral cortex, but rather sends dense, GABAergic inhibitory projections 
to the other thalamic nuclei (Mitrofanis and Guillery, 1993; Steriade et al., 1997; Pinault and 
Deschenes, 1998; Deng and Elberger, 2003; Ferrarelli and Tononi, 2011). Hence the TRN is 
in an anatomically strategic position to modulate the flow of information between the cortex 
and thalamus.   
 
Thirty years ago Crick proposed the ‘searchlight hypothesis’ for the TRN (Crick, 1984) noting 
that if the thalamus acted as a gateway to the cortex then the TRN acts as a guardian of that 
gateway (reviewed in (Pinault, 2004; Ferrarelli and Tononi, 2011). In other words,consistent 
with the idea thatthe TRN enables the focussing of information to facilitate salient stimuli and 
suppress irrelevant stimuli. Since that time, a body of evidence has accumulated to support 
an involvement of the TRN in sensory gating, attentional modulation, sleep spindles, ³  
oscillations, emotional salience and cognitive flexibility. These aspects of neural function are 
all notably disrupted in patients with schizophrenia, consistent with the TRN playing a key 
role in the disease. Nevertheless, the study of the direct involvement of the TRN in 
pathological and physiological processes has been hampered by the limitations in 
technology available to date to precisely probe the function of this thin layer of cells 
  
. 
. 
 
1) TRN: functional anatomy, neurotransmitter receptors and physiology 
 
As illustrated in Figure 1, there are reciprocal glutamatergic excitatory connections between 
thalamic nuclei and the cortex, which also send collateral projections to the TRN. The TRN 
provides a powerful means to modulate this circuitry via inhibitory GABAergic projections to 
thalamic nuclei. The inhibitory output of TRN neurones is largely dependent on the level of 
excitatory drive to these cells from the cortex and thalamus, and in part by synaptic 
mechanisms within the TRN. It is notable that collateral projections from many 
thalamocortical neurones and  corticothalamic neurones innervate a single TRN GABAergic 
neurone which in turn sends projections to many thalamocortical neurones. The large and 
convergent receptive fields for the TRN inhibitory cells has led to the idea that the TRN has 
an integrative role (Pinault, 2004) 
 
The TRN was at one time thought to have non-specific diffuse projections within the 
thalamocortical system.  However, there is now strong evidence that TRN projections to 
sensory-related ‘first-order’ thalamic nuclei are topographically organised although 
projections to ‘higher-order’ thalamic nuclei tend to be diffuse. (Guillery et al., 1998; 
Ferrarelli and Tononi, 2011).  Discrete sectors in the TRN are considered to represent 
distinct modalities.  These comprise sensory (auditory, visual, gustatory, visceral and 
somatosensory), motor, limbic and cognitive modalities.  Whilst there is some anatomical 
overlap, the anterior ventral regions of the TRN are associated with the cognition-related 
mediodorsal nucleus of thalamus (MD) whereas limbic regions are associated with the 
anterior dorsal TRN.  Visual and auditory projections are located more caudally, in dorsal 
and medial positions respectively (see (Guillery et al., 1998); (Pinault, 2004).   
 
Each sector of the TRN receives projections from corresponding cortical and thalamic 
neurones and projects back to the thalamic nucleus which innervates it. The thalamic nuclei 
have been classed as ‘first’ or ‘higher’ order (Sherman, 2001). Afferents to these nuclei arise 
from a range of sources and are classed as ‘drivers’ (Class 1) or ‘modulators’ (Class 2).  The 
driving inputs, convey the message that is to be transmitted to the cortex whereas the 
modulators (which constitute the majority of the inputs onto thalamic relay cells) modify the 
way the message is to be communicated or whether it is conveyed at all (Sherman and 
Guillery, 2002)(Murray et al., 2007). 
 
 The ‘first-order’ thalamic nuclei (e.g. lateral geniculate in the visual thalamus and ventral 
part of medial geniculate in the auditory thalamus) receive projections from ascending 
sensory inputs and relay this information from the periphery to the cortex (typically layer IV). 
The afferent driving inputs (from auditory, visual and somatosensory pathways), along with 
the modulating inputs from the TRN, brain stem nuclei and interneurones, make multiple 
synaptic contacts onto thalamic relay cells, forming a ‘triadic’ junction (or glomerulus) which 
has a distinctive microscopic appearance (See (Guillery and Sherman, 2002).  
 The ‘higher-order’ (HO) thalamic nuclei (e.g MD thalamus, midline and intralaminar nuclei) 
receive driving inputs from collaterals of layer V cortical neurones (which are en route to 
motor centres in the brain stem and spinal cord). and convey information back to the cortex 
(typically layer IV) where information is also transmitted to other cortical regions 
(corticocortical connections). The HO nuclei also receive inputs from layer IV of the cortex 
(as do the first order thalamic nuclei and TRN) and, as noted above, projections from the 
TRN which tend to be diffusely organised (Lam and Sherman, 2007).  This pattern of 
connectivity has led to the proposal that the HO thalamic nuclei are not only able  to transmit 
relevant information to the cortex but also have the capacity to inform other cortical areas 
about instructions being sent to subcortical regions (Guillery and Sherman 2002)(Guillery 
and Sherman, 2011; Sherman and Guillery, 2011). The potential mechanisms through which 
HO nuclei may regulate transmission in cortical circuits in the context of cognitive processing 
is the subject of a recent review (Saalmann, 2014).  Importantly, the widespread projections 
of the TRN to the HO thalamic nuclei suggest that the TRN could play a key role in 
regulating transthalamic corticocortical communication through its ability to modify the mode 
of firing of thalamocortical cells (Guillery and Sherman, 2002)(Vukadinovic, 2011)).  
 
Collaterals from the prefrontal cortex (PFC) and MD (which provides the major thalamic 
innervation of the PFC) terminate more widely in the TRN than collaterals from other cortical 
and thalamic areas (Zikopoulos and Barbas, 2007), suggesting a particularly effective gating 
of thalamic relay activity by PFC circuits (Fig 1). In addition, recently discovered TRN 
afferents from the amygdala (Zikopoulos and Barbas, 2012) implicate the TRN in imparting 
emotional salience to thalamic filtering of sensory information.   
 
 
A key feature of the TRN neurones is that they can fire in two different modes: short lasting 
high frequency bursts and a tonic firing  mode. Low voltage-activated T type calcium 
channels play a key role in enabling TRN neurones to generate rhythmic bursts of action 
potentials, which in turn are thought to be important in the generation of thalamocortical 
oscillations. Indeed the TRN has been shown to be important in a range of different rhythms 
including sleep spindles, slow oscillations and delta and gamma rhythms (Macdonald et al., 
1998a; Huguenard and McCormick, 2007). 
At the single cell level, the glutamatergic thalamocortical and GABAergic TRN neurones are 
not reciprocally connected. Rather, they form open-loop connections in which only 1 of 2 
neurones innervates the other in a 2 neurone circuit.  Operationally, such a 2 neurone 
GABAergic-glutamatergic circuit functions via lateral inhibition principles (see (Pinault, 2011) 
for fuller explanation).  Pinault (2011) argues that this process enables the TRN cells to 
modulate thalamocortical cells efficiently in order to amplify relevant information that should 
be conveyed to the cortical areas, and to delete/reduce non-relevant or distracting 
information.  
 
Whilst the TRN neurones are GABAergic (Houser et al., 1980; Mitrofanis and Guillery, 1993; 
Steriade et al., 1997), they also contain high levels of the calcium-binding protein 
parvalbumin, along with certain neuropeptides such as TRH, VIP and NPY (Morris, 1989; 
Burgunder et al., 1999) and the endocannabinoid 2-AG (Sun et al., 2011). Calcium binding 
proteins such as parvalbumin play an important role in regulating intracellular availability of 
Ca+, and hence modulation of membrane potential, synaptic transmission and firing patterns 
of TRN neurones. 
The TRN is rich in glutamate and GABA receptors, and expresses a range of other 
receptors including acetylcholine (M2,  ±4² 2, ±7) (Rubboli et al., 1994; Sun et al., 2013b), 
serotonin (5-HT1A and 5-HT2A) (Rodriguez et al., 2011), dopamine (D1 D2 and D4) (Zhang 
et al., 2009; Govindaiah et al., 2010), cannabinoid (CB1) (Sun et al., 2011) and melatonin 
(MT2) (Comai and Gobbi, 2014) receptors (Fig 2).  This neurochemical signature supports a 
regulatory influence of a range of neuromodulatory systems on TRN activity (see below). 
 
 
The TRN GABAergic neurones communicate with each other via both electrical and 
chemical synapses, the former clearly playing an important role in synchronisation of TRN 
output, while the latter potentially restrict the numbers of TRN neurones contributing at that 
time to rhythmic oscillations (Sohal and Huguenard, 2003). A reduction in intra-TRN 
communication can hence over-synchronise output, and potentially lead to seizure-like 
activity (Huntsman et al., 1999).   
 
Within the TRN, neurones are interconnected by a network of GABAergic synapses. 
GABA(A) receptor evoked depolarisations can interact with T-type Ca(2+) channels to 
powerfully control burst firing in TRN neurones, which results in feed forward  inhibition in 
thalamic relay cells. This information is transmitted back to RTN cells through axon 
collaterals of projections (Llinas and Jahnsen, 1982; Huguenard, 1996; Sun et al., 2012). 
These events are mediated by activation of predominantly postsynaptic GABAA receptors 
with an additional contribution of GABAB receptors during intense TRN output (Huguenard 
and Prince, 1994; Sun et al., 2012). 
 
Glutamate released from glutamatergic inputs to the TRN from the cortex and the thalamus 
acts upon a range of glutamate receptors in the TRN, with postsynaptic NMDA receptors 
considered to play an important role  (Jones et al., 1998; Zhang et al., 2009). It has been 
argued that thalamic circuitry is potentially vulnerable to excessive glutamatergic cortical 
drive to the RTN or intensive GABAergic inhibition of thalamocortical relay neurones by 
neurones of the reticular thalamus. Hence physiological mechanisms that enable fine tuning 
of this circuit activity are required to protect against prolonged activity in the network.  A 
range of presynaptic receptors may fulfil this role.  For example, metabotropic receptors may 
play a protective role by suppressing synaptic release.  Activation of mGluR3 and mGluR4/8 
receptors modulates the activity of glutamatergic cortical synapses onto RT neurones, and 
GABAergic synapses onto thalamocortical neurones in the somatosensory thalamus, with 
the overall effect of suppressing thalamic oscillations (Gu et al., 2008; Kyuyoung and 
Huguenard, 2014). Similarly the endocannabinoid system may play a critical role in 
maintaining thalamic synchrony.  Under conditions of increased levels of intra TRN synaptic 
activity, a presynaptic CB1 receptor dependent suppression of inhibitory synaptic strength 
has been shown which is potentially mediated through alterations in the release of 2-AG 
from TRN neurones (Sun et al., 2012).  
 
Furthermore, there is in vitro evidence that tonically active presynaptic NMDA receptors and 
mGlu2Rs act in concert with postsynaptic NMDA and GABA receptors (Crabtree et al., 
2013). It is argued that when TRN neurones are relatively hyperpolarised their ability to fire 
in burst mode will be enhanced, whereas when these neurones are relatively depolarised 
their firing in single-spike tonic mode will be reduced (Crabtree et al., 2013). 
 
 
The roles of other receptors in shaping TRN activity are beginning to be understood, 
predominantly from in vitro electrophysiological studies conducted in brain slices.  Dopamine 
inhibits GABA transmission from the globus pallidus to the TRN through an action at D4 
presynaptic receptors, but does not affect intra TRN activity (Govindaiah et al., 2010). 
Serotonergic neurones project from the dorsal raphe to all areas of the RTN, where 5-HT 
released acts upon 5-HT1A and 5-HT2A receptors to modulate TRN activity (Rodriguez et 
al., 2011). Similarly, acetylcholine release from cholinergic neurones arising from the basal 
forebrain and the pedunculopontine and laterodorsal nuclei of the brain stem also modulates 
TRN activity. This occurs via actions at postsynaptic ionotropic nAChRs located on dendrites 
and pre- and postsynaptic mAChR receptors (for review see (Beierlein, 2014).  Interestingly 
the same low frequency input can generate both excitation (via ±4² 2 nAChR) followed by 
inhibition (via M2 mAChR) (Sun et al., 2013b).  Sun et al (2013) note that the activation of 
postsynaptic nAChRs by acetylcholine release from a small number of axons is enough to 
trigger action potentials in TRN neurones. Moreover, short trains of cholinergic synaptic 
inputs can powerfully entrain ongoing TRN neuronal activity. The M2 mAChRs appear to 
play a key role in controlling nAChR-mediated excitation through their ability to inhibit ACh 
release (via presynaptic M2 autoreceptors) and via M2 mediated postsynaptic 
hyperpolarisation (Sun et al., 2013b; Beierlein, 2014). 
 
Agonists at the melatonin 2 receptor have also been shown to increase the neural activity of 
the reticular thalamus, enhancing the rhythmic burst activity and promoting non REM sleep 
(Ochoa-Sanchez et al., 2011). 
 
2) The role of the TRN in relation to oscillatory activity, cognition and behaviour  
 
 
Oscillatory activity, 
The constant activity of the cerebral cortex as recorded by the EEG or within brain regions 
as local field potentials (LFPs) largely results from the interacting oscillations (rhythms) of 
neuronal networks.  The frequencies of these oscillations, which are preserved across 
mammals, span 0.05-500HZ and include sleep spindles (12-18HZ), theta- (4-10HZ) and 
gamma-band oscillations (30-90HZ) (Buzsaki and Draguhn, 2004).  Most forms of 
oscillations are inhibition based and in this respect the GABAergic neurones of the TRN play 
an important role.  
The TRN is involved in the generation of ‘sleep spindles’ characteristic of stage 11 sleep and 
gamma oscillations, where repetitive TRN bursting produces rhythmic inhibition of the 
thalamocortical pathways (Steriade et al., 1985; Pinault and Deschênes, 1992; Macdonald et 
al., 1998b), Oscillations in the gamma range are linked to cognitive processes in the adult 
(Osipova et al., 2006; Colgin et al., 2009), and underpin plasticity at thalamocortical 
synapses during development (Minlebaev et al., 2011). Theta rhythms also play a role in 
memory processes (Osipova et al 2006).  Operationally gamma and theta rhythms are 
proposed to work together to form a neural code that optimises cognitive processing. (for 
review see (Lisman and Buzsaki, 2008). 
 
Recent technological advances such as optogenetics are dissecting the role of specific cell 
types and circuits in the TRN, and for the first time providing a direct link between TRN 
activity and behaviour. Optogenetic stimulation of the TRN, using a GABAergic promoter-
driven expression of channelrhdopsin 2 (Halassa et al., 2011), exploiting the relative paucity 
of GABAergic interneurones in the vicinity of the TRN, demonstrated that the TRN generates 
cortical spindles supporting results from previous lesioning studies.  Furthermore, using 
recordings from microelectrode arrays in behaving mice, the same group discovered 
functional diversity amongst TRN microcircuits. Two TRN subpopulations were discovered, 
one that correlated with spindles and the other that correlated with arousal (Halassa et al., 
2014)   
 
Cognition and behaviour 
The basis of the Crick hypothesis (Crick, 1984) is that the TRN acts as an ‘attentional 
searchlight’. Some support for this hypothesis has arisen from lesion and histological studies 
in rodents.  In an attentional orienting task, lesions of the visual TRN produced deficits in 
behaviour, supporting a link between the TRN and the attentional effects of visual cues 
(Weese et al., 1999). Another study showed that there was an increase in c-Fos expression 
in a sector of the TRN that correlated with the modality of an attended stimulus (McAlonan 
and Brown, 2002).  However given that the TRN is a thin layer of cells, lesioning approaches 
may impact on the function of surrounding thalamic nuclei.  Furthermore, lesions are likely to 
impact on both thalamocortical and corticothalamic axon collaterals to the TRN.  This would  
mean that not only is the TRN isolated from thalamic circuitry but that the functional 
networks passing through are removed. Together, these factors limit the interpretation of 
lesioning data. Changes in immediate early gene expression in relation to behaviour are 
also limited in the sense that they are correlative in nature.   
 
Important investigations in primates have produced more direct evidence to support the 
Crick hypothesis.  McAlonan et al. (2006) recorded visual TRN neurones in awake monkeys, 
and the modulation of the response as the monkeys shifted attention between visual and 
auditory stimuli. They demonstrated that TRN activity is modified by shifts of visual attention, 
and that these changes in attention could affect visual processing in the lateral geniculate 
thalamic nucleus via the inhibitory connections back to the thalamus.  They conclude that 
the TRN contributes to attentional processing, whereby a relevant sensory input is selected 
for additional processing at the expense of an irrelevant input.  Whilst the sensory regions of 
the TRN have been investigated in attentional tasks, the contributions of the ‘cognitive’ 
related TRN inputs, from the PFC and via the MD, have not been explored. The PFC-MD-
TRN circuitry is likely to play a prominent role in cognitive flexibility and working memory, 
and hence future studies that investigate the role of the TRN in tasks that reflect these 
cognitive domains will be important.  
 
In an elegant recent study, Halassa et al. (Halassa et al., 2014) for the first time combined 
multi electrode recordings of the TRN with optogenetics. Optogenetics enables good 
temporal and spatial resolution and most importantly it enables thalamocortical and 
corticothalamic axons to stay intake during TRN inhibition/excitation.  Using the same 
optogenetic strategy as in their earlier work (Halassa et al., 2011), retrograde lentiviruses 
containing light-activated ion channel channelrhodopsin-2 were injected into the sensory 
visual or anterior limbic thalamus of VGAT (vesicular GABA transporter)-Cre mice.  Clear 
differences were found in the functionality of these TRN projection neurones, with visually-
tagged neurones showing correlations to cortical spindle power during slow wave sleep 
whereas limbic-tagged neurones were negatively correlated. Importantly, during a visual 
detection task that required attention there was a reduction in firing rate for visual-projection 
neurones but not limbic-projection TRN neurones. Since the reduction in activity of vision 
associated TRN neurones occurred after the onset of a trial but just before the stimulus 
presentation, the authors suggest that these neurones are involved in attentional states. 
This conclusion was further supported using an alternative optogenetic strategy to reduce 
the firing rate of sensory TRN neurones further (using eNpHR3.0, a light activated Cl- pump 
that hyperpolarises cells and inhibits spiking) in response to which the mice showed the 
predicted increase in behavioural performance. The authors raise the possibility that the 
demonstrated distinct subgroups of TRN neurones can facilitate the switching from attention 
to external stimuli to an internal focus. Specifically, they suggest that TRN engagement may 
contribute not only to “offline” consolidation of memory processes, but also to dynamic 
conversion between default mode and cognitive-control networks. This is intriguing, given 
the abnormal default mode network connectivity in schizophrenia (Whitfield-Gabrieli et al., 
2009). 
. 
The TRN and schizophrenia risk factors: preclinical evidence  
 
Converging evidence from preclinical studies in rodents strongly supports the hypothesis 
that TRN dysfunction may play an important role in the disease process. NMDA receptor 
(NMDA-R) glutamatergic antagonists such as ketamine and phencyclidine are able to induce 
a variety of effects in humans and rodents that resemble the positive, negative and cognitive 
symptoms of schizophrenia The effects are observed with acute administration, but are 
consolidated and exacerbated by repeated administration (Krystal et al., 1994; Tamminga, 
1998; Morris et al., 2005; Pratt et al., 2012).  
 
We have shown that rats receiving chronic, intermittent treatment with a low dose of the 
NMDA-R antagonist phencyclidine (PCP) develop metabolic hypofrontality and PFC GABA 
interneurone deficits that parallel those in the brains of patients with schizophrenia (Cochran 
et al., 2003). Chronic PCP treatment also reduced metabolic activity and GABAergic marker 
levels (e.g. PVALB) in the TRN (Cochran et al., 2003). Importantly, the changes in the TRN 
actually preceded those in the PFC (Cochran et al., 2002). Indeed, cortical PVALB 
expression is known to be regulated by TRN lesions (Alcántara et al., 1996). Hence the CNS 
changes particularly characteristic of schizophrenia – prefrontal cortex inefficacy (Tamminga 
et al., 1992; Hill et al., 2004; Molina et al., 2005; Potkin et al., 2009) and PFC GABAergic 
deficits – may occur secondary to TRN dysfunction.  This speculative idea highlights the 
importance of understanding the neurobiological processes through which the TRN may 
impact on cortical function.  
Acute administration of NMDA-R antagonists in rats also induces various effects on 
thalamocortical circuitry: a) elevated glutamate release in the PFC, although the site of 
action of the NMDA-R antagonists appears to be outwith the PFC (Lorrain et al., 2003; 
Lopez-Gil et al., 2007); b) c-fos induction in the PFC and medial thalamus but not in the 
TRN, consistent with a disinhibition of thalamocortical circuits (Kargieman et al., 2007; 
Santana et al., 2011); c) increased metabolic activity in the PFC (hyperfrontality), but 
reduced metabolism in the TRN (Dawson et al., 2013). It was previously thought that NMDA-
Rs on PFC PVALB-positive interneurones were the locus of action for the hyperfrontality and 
increased activity of prefrontal cortex pyramidal cells (Homayoun and Moghaddam, 2007)   
following acute ketamine/PCP, but opinion is now shifting away from this idea (Rotaru et al., 
2011; Povysheva and Johnson, 2012).  Thalamic neurones have also been implicated in the 
actions of NMDA receptor antagonists since PCP alters the activitiy of thalamic relay 
neurones of the MD and centromedial (CM) thalamus along with mPFC neurones in 
anaesthetised rats (Santana et al., 2011).  Furthermore microinjections of MK801 into the 
MD thalamus, but not the PFC, modulates cortical delta band activity in anaesthetised 
animals similar to that observed following systemic administration (Kiss et al., 2011).  
Because the TRN provides tonic feed forward inhibition to thalamic nuclei, changes in 
MD/CM activity could result from NMDA receptor blockade in the TRN. NMDA-Rs in the TRN 
are active under resting conditions (Jacobsen et al., 2001; Gentet and Ulrich, 2003; Zhang et 
al., 2009), probably because TRN NMDA-Rs contain the NR2C subunit, and hence show 
little voltage dependent block at resting potentials. Metabolic hyperfrontality can be induced 
by elevated activity in PFC afferents (Canals et al., 2009), and so the increased 
metabolism/activity in the PFC induced by ketamine/PCP may reflect increased 
thalamocortical activity, due to disinhibition, caused by blockade of NMDA-R drive of 
GABAergic TRN neurones. Indeed functional connectivity analysis following acute ketamine 
treatment in rodents provides evidence to support this hypothesis (Dawson et al., 2013)  as 
do recent in vivo electrophysiological studies which showed inhibition of TRN activity after 
PCP (Troyano-Rodriguez et al., 2014). 
 
In terms of schizophrenia-relevant cognitive behaviours, indirect support for a role for the 
TRN in PCP-induced attentional set shifting deficits stems from findings of altered 
expression of Zif268 and parvalbumin in the TRN and infralimbic cortex in animals that 
exhibited behavioural deficits (Egerton et al., 2005).  Changes in attentional set shifting 
induced by PCP provide some translation to schizophrenia where deficits occur in the 
analogous components of the CANTAB task.  
In summary, accumulating evidence is consistent with altered PFC function induced by 
NMDA-R antagonist treatment being secondary to a primary site of action in the TRN.  
 
In terms of genetic risk factors for schizophrenia, DISC1 has attracted considerable 
attention.  The DISC1 gene is located on chromosome 1q42.1, and an abnormal  
translocation  in this gene increases the risk of developing schizophrenia, bipolar disorder, or 
major depression by ~50 fold in comparison to the general population (Millar et al., 2000; 
Brandon et al., 2009) DISC1 expression is apparent in schizophrenia-relevant regions such 
as the prefrontal cortex, hippocampus and TRN.  Of particular relevance are the findings that 
DISC1 is highly expressed in the TRN during periods of development when corticothalamic 
connections are forming, and that during the developmental period the TRN is relatively 
larger than the adult size (Mitrofanis and Guillery, 1993; Austin et al., 2004).  Taken together 
these findings suggest that DISC1 in the TRN could play a critical role in the formation of the 
thalamocortical system, and provide an explanation for the vulnerability to schizophrenia 
arising from the impact of genetic abnormalities on this circuitry during the 
neurodevelopmental period.  In order to assess the impact of the DISC1 translocation upon 
adult brain function we have determined the brain imaging signatures of mice with 
modifications in the DISC1 gene.  We have demonstrated that the TRN is a key brain region 
affected in these mice (Dawson et al., 2014) adding further weight to the concept that TRN 
dysfunction may be a key factor in the aetiology of schizophrenia. 
 
4 Clinical evidence for TRN dysfunction in schizophreniaThere is abundant evidence for 
thalamic impairment in schizophrenia. Structural studies (through both MRI imaging and 
post-mortem stereology) show fairly consistent reductions in tissue volume, both for total 
thalamic volume and for the MD nucleus in particular (Clinton and Meador-Woodruff, 2004; 
Byne et al., 2009; Pakkenberg et al., 2009; Janssen et al., 2012). Altered levels of 
expression of glutamate receptors, glutamate transporters and post-synaptic proteins 
(PSD95 and SAP102 transcripts) are observed in postmortem thalamic tissue from patients 
(Clinton and Meador-Woodruff, 2004), suggesting disruption of glutamate signalling in the 
thalamus in the disease. Of potential future interest would be to investigate the NR3 receptor 
given its importance in neurodevelopment (Sun et al., 1998), and the fact that increased 
expression would compromise plasticity in thalamocortical circuits. Recent imaging studies in 
high risk subjects suggest that abnormal glutamate levels in the thalamus may be one of the 
earliest neurobiological signs associated with the development of psychosis (Fusar-Poli et 
al., 2011). Functional imaging has also confirmed thalamic abnormalities in patients, 
generally suggestive of reduced activity (Andreasen et al., 1994; Buchsbaum et al., 1996; 
Hazlett et al., 2004; Hazlett et al., 2008; Minzenberg et al., 2009). Hence abnormal function 
of corticothalamic and thalamocortical pathways is clearly a component of the network 
dysfunction in schizophrenia (Andreasen et al., 1995; Andreasen et al., 1996; Buchsbaum 
and Hazlett, 1998; Anticevic et al., 2013). 
  
On the thalamic side of this disrupted network, there appears to be a regional selectivity 
(Andreasen, 1997; Jones, 1997) that parallels disease-specific changes in cortical structure, 
activity, connectivity and neurochemistry. Thus cortical abnormalities are centred on 
prefrontal, cingulate and temporal areas (Hill et al., 2004; Cole et al., 2011; Shepherd et al., 
2012; Haijma et al., 2013), with thalamic pathology and connectivity deficits most evident in 
thalamic nuclei connected with the most-affected areas of cortex. Thus abnormalities in MD 
and anteroventral thalamus have been frequently reported (Danos et al., 1998; Young et al., 
2000; Kemether et al., 2003; Hazlett et al., 2004; Andrews et al., 2006; Shimizu et al., 2008; 
Byne et al., 2009), while evidence for dysfunction in other parts of the thalamus, such as the 
lateral geniculate nucleus for example, is sparse. Despite its well-known role in modulating 
and synchronising activity in thalamocortical loops, and especially in limbic thalamocortical 
loops, the TRN has been relatively neglected in relation to schizophrenia. As noted earlier in 
this review, the widespread projections of the TRN to the higher order thalamic nuclei 
suggest that the TRN could play a key role in regulating transthalamic cortico-cortical 
communication through its ability to modify the mode of firing of thalamocortical cells (Byne 
et al., 2009)(Guillery and Sherman, 2002{Vukadinovic, 2011 #4103). The consequences of a 
disrupted pattern of connectivity in thalamic-TRN-cortical circuitry leading to impaired 
transthalamic corticocortical communication could result in the incorrect assignation of the 
relevance of a stimulus, the cortex processing information with only limited information about 
its context and potentially the inability to determine whether a stimulus is externally or 
internally derived.  Such dysfunction could result in many of the symptoms of schizophrenia 
(see reviews by Byne et al 2009; Vukadinovic 2011) 
 
Although limited, evidence from a variety of different sources is now focussing attention on 
the TRN as a key area of dysfunction in patients. 
 
Recent reports implicate TRN dysfunction directly in some of the core neurophysiological 
changes characteristic of schizophrenia (Ferrarelli and Tononi, 2011; Pinault, 2011). Neural 
oscillations, as detected using techniques such as electroencephalography or (more 
sensitively) magnetoencephalography represent co-ordinated electrical activity in 
interconnected brain regions, sustaining processes such as attention and cognition that 
require synchronised activity between cortical and sub-cortical areas (Fries et al., 2007; 
Womelsdorf et al., 2007). It is now appreciated that the TRN plays a major role in the 
synchronisation of thalamocortical and corticothalamic activity (Pinault, 2004), and hence in 
the control of gamma (high frequency) oscillations (Huguenard and McCormick, 2007; 
Jones, 2009). Gamma oscillations can be maintained locally in cortical networks, but 
evidence suggests that these are likely to be regulated by the TRN influence on 
thalamocortical loops (Pinault, 2004). The literature on disturbances in gamma oscillations in 
schizophrenia is not always consistent (Uhlhaas and Singer, 2010). Nevertheless, the 
general picture is that this high-frequency oscillatory activity is compromised in 
schizophrenia. Reduced levels of spontaneous and evoked cortical gamma oscillations are 
typically detected in patients, in association with sensory processing or performance of 
executive tasks (Rutter et al., 2009; Uhlhaas and Singer, 2010; Sun et al., 2013a). The 
abnormal gamma oscillatory activity in schizophrenia may therefore be sending a strong 
signal that TRN dysfunction is a fundamental component of the disease. 
 
Considering the relationship between oscillatory activity and cognition, the characteristic 
cognitive deficits of schizophrenia may be directly connected with these impairments. 
Gamma band oscillations are linked with performance of working memory tasks (Yamamoto 
et al.; Howard et al., 2003; Roux and Uhlhaas, 2014), where patients show impairment 
(Perlstein et al., 2001; Bor et al., 2011). Indeed, the deficits in gamma oscillatory activity in 
patients are correlated with working memory deficits (Cho et al., 2006). The TRN has been 
particularly strongly linked with attentional mechanisms (Weese et al., 1999; Zikopoulos and 
Barbas, 2012) – and  deficits in attentional processes are characteristic of schizophrenia 
(Andreasen et al., 1995; Buchanan et al., 1997; Birkett et al., 2007). Equally, the positive 
symptoms of schizophrenia can also be readily equated with deficient thalamic filtering of 
sensory information, and thus with impaired modulation of thalamocortical feedback by the 
TRN.  
 
As with the control of thalamocortical synchronisation during consciousness and cognition, 
the TRN also plays a central role in the control of rhythmic activity during sleep. The TRN is 
believed to act as the pacemaker for sleep spindles – slow frequency oscillations that occur 
particularly during the early stages of sleep (Fuentealba and Steriade, 2005; Halassa et al., 
2011; Kim et al., 2012). Patients with schizophrenia exhibit disturbed sleep patterns, with 
increased sleep latency and more frequent night awakenings (Keshavan et al., 1995; Cohrs, 
2008; Sarkar et al., 2010). This disturbed sleep is associated with a marked reduction in the 
density and coherence of sleep spindles (Ferrarelli et al., 2010; Wamsley et al., 2012; 
Gardner et al., 2014), with the degree of sleep spindle impairment correlating strongly with 
sleep pattern deficits. These deficits are not drug-induced effects, since they are observed in 
antipsychotic-naive patients. There is increasing acceptance that sleep problems are in fact 
a core symptom of schizophrenia (Wilson and Argyropoulos, 2012), also present in ultra-high 
risk subjects prior to the onset of psychosis (Ruhrmann et al., 2010; Lunsford-Avery et al., 
2013). This in itself implicates TRN dysfunction in the development of the disease. 
Potentially NMDA receptor hypofunction on TRN cells could result in impaired transthalamic 
cortico-cortico communication leading to sleep spindle deficits (Vukadinovic, 2011). 
There is a paucity of data from imaging or postmortem pathology studies to assess the 
degree of TRN dysfunction in schizophrenia. Unfortunately the TRN is too narrow to be 
resolved by current in vivo imaging methodologies such as PET or fMRI. However, a  recent 
functional imaging combined with transcranial magnetic stimulation showed thalamic 
dysfunction in schizophrenia (Guller et al., 2012), which may also implicate altered TRN 
function given the strong functional connectivity between the TRN and thalamic nuclei. In 
addition, altered TRN expression of nicotinic cholinergic α7 receptors and glutamate 
transporters (EAAT1-3) has been reported in post-mortem tissue from patients (Court et al., 
1999; Smith et al., 2001), but otherwise there is little information on possible neurochemical 
or neuropathological changes in the TRN. Future studies should address this issue as a 
matter of urgency. 
 
It is worth noting, however, that TRN involvement in the fundamental network dysfunction in 
schizophrenia is consistent with known environmental and genetic influences on disease risk 
(for recent reviews see (Modinos et al., 2013; Rethelyi et al., 2013). The TRN is particularly 
vulnerable to ischaemic episodes (Ross and Duhaime, 1989), including perinatal ischaemia 
(McQuillen et al., 2003), and also to malnutrition during development (Salas et al., 1986). As 
noted above, during development, the TRN shows some of the highest expression in the 
brain of the DISC1 gene (Austin et al., 2004), and genetic disruption of DISC1 dramatically 
increases the incidence of psychiatric disease (Millar et al., 2000). Hence genetic and 
environmental risk factors may interact at the level of the TRN to initiate circuit dysfunction 
and deficits in thalamocortical information processing. As noted above, evidence from a 
variety of sources suggests that this would be sufficient to drive schizophrenia-like 
biochemical and metabolic changes in PFC and hippocampus, and initiate some behavioural 
changes characteristic of the disease. Previously, dysfunctional GABAergic interneurones of 
the PFC have been a focus for the impaired PFC activity in schizophrenia, but arguably this 
focus could now be shifted to TRN GABAergic neurones as potential drivers of some of the 
PFC changes and hence for the TRN itself to contribute to the symptoms of schizophrenia. 
 
 
Implications for drug discovery   
Based upon the accumulating evidence that the TRN plays a role in thalamocortical and 
transthalamic cortico-cortico communication dysfunction in schizophrenia, it is reasonable to 
suggest that drugs which target receptors localised in the TRN could have the ability to 
restore circuitry dysfunction resulting in improvements in a range of symptoms.  Both 
postsynaptic and presynaptic receptors are important in modulating TRN activity (see 
section 1 and Fig 2).  Presynaptic receptors that offer potential as drug targets include the 
mGlu2/3 agonists.  Indeed initial clinical trials proved promising with a Glu2/3 agonist 
although more recent studies have proved inconclusive (Patil et al., 2007; Adams et al., 
2013).  Another interesting target is the postsynaptic nicotinic alpha 7 receptor and clinical 
trials suggest potential beneficial effects of alpha 7 receptor agonists on negative symptoms 
and cognitive deficits (Freedman et al., 2008). Restoration of GABAergic dysfunction in the 
TRN with GABAA receptor positive allosteric modulators could be another option. Indeed this 
concept has been proposed for modulation of PFC parvalbumin containing GABAergic 
neurones known to be deficient in schizophrenia (Volk and Lewis, 2005).  Arguably if the 
TRN is the driver of PFC-induced changes then the action of drugs in the TRN could be the 
fundamental basis for treatment. Of the 5-HT receptors localised in the TRN, 5-HT2A 
receptors are of interest given that many current antipsychotic drugs show affinity for these 
receptors.  Understanding how these receptors modulate thalamocortical function at the 
level of the TRN and the relationship with specific symptom domains is an important 
question. Similarly, understanding how other receptors such as CB1 receptors can modify 
TRN activity at the level of specific modalities will provide greater insight into the potential of 
compounds to restore particular symptom domains.  Ultimately the orchestration of TRN 
activity depends on a complex interplay of a range of neurotransmitters that modulate pre- 
and post- synaptic activity. Gaining greater insight into the precise role of these receptors in 
the topographical organisation of the TRN, their relationship with particular physiological 
processes and how these may be dysfunctional in schizophrenia is important not only from a 
disease mechanism perspective but informative for drug discovery. 
 
In summary, despite the strong indications from both preclinical and clinical areas for 
disease-related TRN dysfunction, much more research is required to understand the 
neurobiology of the TRN in relation to thalamic and cortico-cortical communication and to  
demonstrate unequivocally that there is a casual relationship with TRN dysfunction and the 
aetiology of schizophrenia. Ultimately this improved knowledge may lead to more rational 
approaches for drug discovery in schizophrenia. 
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Figure Legends  
 
 
Fig 1.  Schematic diagram of the connections between the Prefrontal cortex (PFC), 
Mediodorsal nucleus of the thalamus(MDN) and the Thalamic reticular nucleus (TRN) 
 
 
Fig 2. Schematic diagram showing afferent inputs to a dendrite of a GABAergic TRN 
neurone together with neurotransmitter receptors.  Cell bodies from cortical, thalamic and 
basal forebrain inputs are represented as triangles and coloured according to the 
neurotransmitter system utilised.  Note that NMDA, AMPA and GABAA receptors are located 
postsynaptically (although presynaptic NMDA receptors also exist). GABAA receptors are 
activated by locally released GABA from nearby TRN GABAergic neurones (not shown). 
mGlu2/3 are located presynaptically.on glutamatergic inputs from the cortex and presynaptic 
CB1 receptors may modify intra TRN GABAergic transmission.  ACh, DA and 5-HT 
receptors are thought to be present postsynaptically although presynaptic receptors may 
also exist (see text for more detail).  
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